ACE2 and viral infectious disease: A study of in vitro severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike pseudotyped viral infection experiments indicated that histamine H1 antagonists loratadine and desloratadine could prevent the entry of the pseudotyped virus into ACE2-overexpressing HEK293T cells and demonstrated that desloratadine was more effective.